当前位置:首页 - 行情中心 - 东北制药(000597) - 财务分析 - 资产负债表

东北制药

(000597)

  

流通市值:71.59亿  总市值:72.50亿
流通股本:14.09亿   总股本:14.27亿

资产负债表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
流动资产:
  货币资金3,750,051,207.543,601,754,773.774,083,712,334.963,829,248,601.2
  交易性金融资产219,635,258.9350,622.3116,137,546-
  应收票据及应收账款2,667,840,059.932,173,677,621.682,671,054,212.732,748,529,255.27
  其中:应收票据465,128,716.45440,776,337.16419,654,016.7424,728,306.28
        应收账款2,202,711,343.481,732,901,284.522,251,400,196.032,323,800,948.99
  应收款项融资131,993,172.2244,430,667.26--
  预付款项87,470,880.82101,303,973.6172,447,485.6851,865,442.44
  其他应收款合计198,374,108.18186,387,478.52204,685,629.66229,492,889.13
  存货1,234,155,356.771,181,565,317.161,138,452,654.531,272,769,661.86
  合同资产4,795,398.745,307,083.08546,995.67663,378.01
  其他流动资产45,905,115.7737,516,857.5541,238,007.6138,812,698.7
  流动资产合计8,340,220,558.857,532,294,394.948,228,274,866.848,171,381,926.61
非流动资产:
  长期股权投资4,730,908.124,730,908.126,127,595.396,127,595.39
  固定资产3,397,072,627.163,488,511,658.13,515,864,753.893,628,679,521.19
  在建工程89,261,392.5499,108,588.14163,709,240.09153,797,026.63
  使用权资产36,668,331.5142,667,221.7843,310,391.1247,563,873.93
  无形资产647,653,095.95661,225,283.51645,285,715.31659,468,951.13
  开发支出755,780,602.57746,063,347.98737,379,835.11729,435,389.58
  商誉153,256,168.7153,403,839.82153,575,788.46153,809,136.73
  长期待摊费用14,789,202.716,654,112.1218,544,452.2320,381,601.16
  递延所得税资产142,872,439.27137,642,962.17123,694,694.32134,635,597.18
  其他非流动资产7,689,396.036,645,538.3312,836,129.9714,171,908.35
  非流动资产合计5,249,774,164.555,356,653,460.075,420,328,595.895,548,070,601.27
  资产总计13,589,994,723.412,888,947,855.0113,648,603,462.7313,719,452,527.88
流动负债:
  短期借款1,669,971,369.151,891,780,154.511,678,800,0001,673,800,000
  交易性金融负债11,792.45---
  应付票据及应付账款3,702,857,897.962,862,420,616.644,025,191,834.694,091,185,646.34
  其中:应付票据2,297,974,224.241,623,928,687.662,660,432,756.862,721,657,187.2
        应付账款1,404,883,673.721,238,491,928.981,364,759,077.831,369,528,459.14
  合同负债75,456,995.7287,902,786.0261,324,713.8161,684,045.82
  应付职工薪酬8,278,943.6836,183,196.512,662,472.543,365,130.37
  应交税费72,085,199.1657,711,519.1840,406,008.3347,643,414.96
  其他应付款合计1,529,499,236.261,439,026,533.991,487,762,214.671,514,727,018.76
        应付股利1,597,979.181,597,979.181,597,979.181,597,979.18
  一年内到期的非流动负债73,912,254.7980,585,388.8179,953,688.1780,155,831.73
  其他流动负债121,104,739.15108,170,723.185,556,201.335,748,951.7
  流动负债合计7,253,178,428.326,563,780,918.847,381,657,133.547,478,310,039.68
非流动负债:
  长期借款154,600,000154,600,000165,600,000166,400,000
  租赁负债19,416,136.5319,815,002.5917,381,996.5721,692,748.92
  预计负债16,350,00016,350,000--
  递延收益121,877,799.34126,202,804.04130,030,225.47133,657,646.9
  递延所得税负债93,778,484.2793,733,27794,808,882.6195,104,213.57
  其他非流动负债246,011,982.06245,207,406.83261,984,952.15260,614,194.35
  非流动负债合计652,034,402.2655,908,490.46669,806,056.8677,468,803.74
  负债合计7,905,212,830.527,219,689,409.38,051,463,190.348,155,778,843.42
所有者权益(或股东权益):
  实收资本(或股本)1,427,088,2651,427,088,2651,427,088,2651,427,088,265
  资本公积2,519,017,553.862,519,017,553.862,486,506,147.372,486,506,147.37
  减:库存股2,471,5602,471,56049,271,56049,271,560
  其他综合收益827,114.011,570,151.872,074,240.652,414,353.85
  专项储备6,171,931.596,272,155.826,295,639.716,328,378.3
  盈余公积205,119,439.95205,119,439.95192,624,557.66192,624,557.66
  未分配利润1,399,896,726.681,373,265,658.31,298,393,165.151,254,868,694.37
  归属于母公司股东权益合计5,555,649,471.095,529,861,664.85,363,710,455.545,320,558,836.55
  少数股东权益129,132,421.79139,396,780.91233,429,816.85243,114,847.91
  股东权益合计5,684,781,892.885,669,258,445.715,597,140,272.395,563,673,684.46
  负债和股东权益合计13,589,994,723.412,888,947,855.0113,648,603,462.7313,719,452,527.88
公告日期2026-04-282026-04-032025-10-282025-08-27
审计意见(境内)标准无保留意见
TOP↑